Predictive value of metabolic and inflammatory indices (TGI, TG/HDL-C, and PIV) for complications in type 2 diabetes mellitus: A retrospective cohort study
Open Access
- 20 February 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (8) , e47725
Abstract
This study aimed to investigate the association between the triglyceride-to-HDL cholesterol ratio (TG/HDL-C), triglyceride-glucose index (TGI), and pan-immune-inflammation value (PIV) with the presence of complications in patients with type 2 diabetes mellitus (T2DM). This retrospective cohort study included 450 patients diagnosed with T2DM between October 2023 and April 2025 at the Department of Internal Medicine, Gaziantep City Training and Research Hospital. Demographic, clinical, and laboratory parameters were collected. TG/HDL-C, TGI, and PIV were calculated using standard formulas. Patients were divided into groups based on the presence or absence of diabetic complications. Comparative, correlation, logistic regression, and ROC analyses were performed to assess the predictive value of these indices. Diabetic complications were present in 63.3% of patients. Patients with complications had significantly higher values of TG/HDL-C (5.24 ± 1.57 vs 4.31 ± 1.21, P < .001), TGI (9.16 ± 0.53 vs 8.68 ± 0.49, P < .001), and PIV (471.2 vs 351.4, P < .001). TGI ( R = 0.68), PIV ( R = 0.65), and TG/HDL-C ( R = 0.62) showed moderate to strong statistically significant correlations with the presence of diabetic complications. In logistic regression, TGI (OR: 2.12), PIV (OR: 1.94), and TG/HDL-C (OR: 1.83) remained independent predictors (all P < .001). ROC analysis revealed high diagnostic accuracy for TGI (AUC = 0.813), PIV (AUC = 0.794), and TG/HDL-C (AUC = 0.782). TGI, TG/HDL-C ratio, and PIV are significantly associated with the presence of diabetic complications and demonstrate strong individual predictive value. Moreover, a combined model integrating all 3 indices further improved diagnostic accuracy (AUC = 0.846), supporting their potential use as complementary tools in comprehensive risk stratification for patients with type 2 diabetes mellitus.Keywords
This publication has 26 references indexed in Scilit:
- Clinical and biological risk factors associated with inflammation in patients with type 2 diabetes mellitusBMC Endocrine Disorders, 2022
- Association of Triglyceride–Glucose Index (TyG index) with HbA1c and Insulin Resistance in Type 2 Diabetes MellitusMædica, 2021
- Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settingsPLOS ONE, 2021
- Predictive effect of triglyceride‑glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in ChinaCardiovascular Diabetology, 2021
- The Role of Inflammation in Diabetic RetinopathyFrontiers in Immunology, 2020
- Association between the triglyceride–glucose index and diabetic nephropathy in patients with type 2 diabetes: A cross‐sectional studyJournal of Diabetes Investigation, 2020
- The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trialsBritish Journal of Cancer, 2020
- The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2Medical Archives, 2019
- Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistanceDiabetology & Metabolic Syndrome, 2018
- IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045Diabetes Research and Clinical Practice, 2018